NO20013891D0 - Sammensetninger omfattende citalopram - Google Patents

Sammensetninger omfattende citalopram

Info

Publication number
NO20013891D0
NO20013891D0 NO20013891A NO20013891A NO20013891D0 NO 20013891 D0 NO20013891 D0 NO 20013891D0 NO 20013891 A NO20013891 A NO 20013891A NO 20013891 A NO20013891 A NO 20013891A NO 20013891 D0 NO20013891 D0 NO 20013891D0
Authority
NO
Norway
Prior art keywords
citalopram
compositions
Prior art date
Application number
NO20013891A
Other languages
English (en)
Other versions
NO20013891L (no
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20013891(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20013891D0 publication Critical patent/NO20013891D0/no
Publication of NO20013891L publication Critical patent/NO20013891L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013891A 2000-08-10 2001-08-09 Sammensetninger omfattende citalopram NO20013891L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
NO20013891D0 true NO20013891D0 (no) 2001-08-09
NO20013891L NO20013891L (no) 2002-02-11

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013891A NO20013891L (no) 2000-08-10 2001-08-09 Sammensetninger omfattende citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (no)
JP (1) JP2003531153A (no)
KR (1) KR20030024833A (no)
CN (1) CN1446089A (no)
AR (1) AR030095A1 (no)
AT (1) AT5744U1 (no)
AU (2) AU2001100198B4 (no)
BE (1) BE1013559A6 (no)
BG (1) BG107578A (no)
BR (1) BR0113250A (no)
CA (1) CA2353693C (no)
CH (2) CH694242A5 (no)
CZ (1) CZ2003397A3 (no)
DE (2) DE20113195U1 (no)
EA (1) EA200300247A1 (no)
ES (1) ES2172481B2 (no)
FI (1) FI5176U1 (no)
FR (1) FR2812811B1 (no)
GB (1) GB2368014B (no)
GR (1) GR1004193B (no)
HR (1) HRP20030054A2 (no)
HU (1) HUP0103071A3 (no)
IE (1) IES20010693A2 (no)
IL (1) IL154050A0 (no)
IS (1) IS6021A (no)
IT (1) ITMI20011637A1 (no)
MX (1) MXPA03000837A (no)
NL (1) NL1018741C1 (no)
NO (1) NO20013891L (no)
NZ (1) NZ523785A (no)
PL (1) PL359824A1 (no)
SK (1) SK2842003A3 (no)
WO (1) WO2001080619A2 (no)
YU (1) YU9003A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
PL378275A1 (pl) * 2002-12-23 2006-03-20 H. Lundbeck A/S Bromowodorek escitalopramu i sposób jego wytwarzania
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
AU2001279591A1 (en) 2001-11-07
GR20010100377A (el) 2002-09-06
BE1013559A6 (fr) 2002-03-05
SK2842003A3 (en) 2003-09-11
ITMI20011637A1 (it) 2003-01-27
PL359824A1 (en) 2004-09-06
CZ2003397A3 (cs) 2003-06-18
IL154050A0 (en) 2003-07-31
EP1318805A2 (en) 2003-06-18
CA2353693C (en) 2003-07-22
AR030095A1 (es) 2003-08-13
DE20113195U1 (de) 2001-11-15
FI5176U1 (fi) 2001-12-27
MXPA03000837A (es) 2003-06-06
HUP0103071A2 (hu) 2002-05-29
CN1446089A (zh) 2003-10-01
GB2368014A (en) 2002-04-24
FR2812811A1 (fr) 2002-02-15
CH694241A5 (de) 2004-10-15
GR1004193B (el) 2003-03-24
HU0103071D0 (en) 2001-10-28
AT5744U1 (de) 2002-11-25
ES2172481A1 (es) 2002-09-16
YU9003A (sh) 2006-05-25
WO2001080619A3 (en) 2002-02-21
NO20013891L (no) 2002-02-11
CA2353693A1 (en) 2002-01-22
GB0118579D0 (en) 2001-09-19
BR0113250A (pt) 2003-06-24
WO2001080619A2 (en) 2001-11-01
NZ523785A (en) 2004-09-24
AU2001100198B4 (en) 2002-06-13
GB2368014B (en) 2004-06-23
AU2001100198A4 (en) 2001-08-16
HRP20030054A2 (en) 2005-02-28
FR2812811B1 (fr) 2006-08-18
BG107578A (bg) 2003-09-30
ES2172481B2 (es) 2004-08-01
NL1018741C1 (nl) 2002-02-12
KR20030024833A (ko) 2003-03-26
HUP0103071A3 (en) 2002-12-28
IS6021A (is) 2001-10-20
ITMI20011637A0 (it) 2001-07-27
IES20010693A2 (en) 2002-07-10
CH694242A5 (de) 2004-10-15
JP2003531153A (ja) 2003-10-21
EA200300247A1 (ru) 2003-06-26
DE10139115A1 (de) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE303787T1 (de) Schergelzusammensetzungen
IS2932B (is) Fúlvestrant samsetning
ATE476975T1 (de) Abführende zusammensetzungen
AR028197A1 (es) Composiciones antitranspirantes
DE60143178D1 (de) Lichtempfindliche Zusammensetzung
DE50113647D1 (de) IR-absorbierende Zusammensetzungen
FI20010780A0 (fi) Parannetut koostumukset
NO20026175L (no) Vaksinesammensetning
AR023440A1 (es) Composiciones antitranspirantes
DE60137637D1 (de) Magnetorheologische fettzusammensetzung
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
DE60111212D1 (de) Flammhemmende polyesterzusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60136220D1 (de) Flammhemmende polyesterzusammensetzungen
NO20013891D0 (no) Sammensetninger omfattende citalopram
FI20000776A (fi) Elintarvikeseos
DE60139896D1 (de) Ldenden zusammensetzungen
DE60116858D1 (de) Zusammensetzung
ATE266316T1 (de) Fungizide zusammensetzungen
ATE268116T1 (de) Mesotrion-formulierungen
DE60016743D1 (de) Schutzschalter
NO20025474D0 (no) Benzofuranderivater
DE50109142D1 (de) Builder-Zusammensetzung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application